Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) insider Christopher G. Hayes sold 33,789 shares of the stock in a transaction on Monday, July 24th. The stock was sold at an average price of $4.83, for a total transaction of $163,200.87. Following the transaction, the insider now directly owns 81,925 shares in the company, valued […]
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Free Report) Director Paul B. Manning bought 200,000 shares of Verrica Pharmaceuticals stock in a transaction on Monday, July 24th. The stock was acquired at an average cost of $5.02 per share, for a total transaction of $1,004,000.00. Following the acquisition, the director now owns 7,851,128 shares in the […]
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Free Report) – Investment analysts at Brookline Capital Management issued their Q1 2024 earnings per share estimates for Verrica Pharmaceuticals in a research note issued on Monday, June 26th. Brookline Capital Management analyst K. Dolliver anticipates that the company will earn ($0.49) per share for the quarter. The consensus estimate […]
Should You Buy or Sell Verrica Pharmaceuticals Stock? Get The Latest VRCA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA – Get Rating) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 301,600 shares, an increase of 24.8% from the February 28th total of 241,600 shares. Approximately 1.2% of the shares of the company are short sold. Based on […]